3 Reasons to Buy Merck Stock Right Now

Like many of its peers in the pharmaceutical industry, Merck (NYSE: MRK) has trailed the broader market in the past year. The effects of the COVID-19 pandemic on trips to doctors' offices coupled with perceived regulatory headwinds (proposed bills that could impact drug sales have been discussed by lawmakers) are probably to blame for this poor performance.

Despite these challenges, there are excellent reasons to consider adding shares of Merck to your portfolio, and some of these are due to recent developments. Here are my top three reasons why Merck stock is a buy right now.

Continue reading

Source Fool.com